Amdocs (FRA:AOS) YoY EBITDA Growth: -34.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AOS Amdocs Ltd FRA:AOS
72 GF Score
Price €52.92
GF Value €75.21
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Amdocs YoY EBITDA Growth?

Amdocs FRA:AOS +2.32% 72 YoY EBITDA Growth is -34.00% as of Jun. 2026. GuruFocus rates FRA:AOS with a GF Score™ of 72/100 and a GF Value™ of €75.21 (Significantly Undervalued). The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Amdocs's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -34.00%.

Amdocs's EBITDA per Share for the three months ended in Jun. 2026 was €1.29.

Amdocs YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Amdocs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amdocs YoY EBITDA Growth Chart

Amdocs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.45 6.30 -8.06 -4.23 11.41

Amdocs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.43 22.74 -5.79 -5.85 -34.00
FRA:AOS
72GF Score
Amdocs Ltd FRA:AOS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amdocs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Amdocs's YoY EBITDA Growth for the fiscal year that ended in Sep. 2025 is calculated as:

YoY EBITDA Growth (A: Sep. 2025 )
=(EBITDA per Share (A: Sep. 2025 )-EBITDA per Share (A: Sep. 2024 ))/ | EBITDA per Share (A: Sep. 2024 ) |
=(7.234-6.493)/ | 6.493 |
=11.41 %

Amdocs's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(1.289-1.953)/ | 1.953 |
=-34.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -34.00% mean?
Amdocs (FRA:AOS) has a YoY EBITDA Growth of -34.00% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Amdocs and its competitors.
Is Amdocs' YoY EBITDA Growth too high?
Amdocs' current YoY EBITDA Growth is -34.00%. Overall, Amdocs has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amdocs' YoY EBITDA Growth compare to PATH and ACIW?
Amdocs' YoY EBITDA Growth of -34.00% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Software company?
A good YoY EBITDA Growth depends on the Software industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Amdocs and its competitors. Amdocs's current YoY EBITDA Growth is -34.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amdocs stock overvalued right now?
Based on GuruFocus' analysis, Amdocs (FRA:AOS) is currently considered Significantly Undervalued. The stock's GF Value™ is €75.21, compared to a current price of €52.92 — trading 29.6% below its estimated fair value. The current YoY EBITDA Growth is -34.00%. Amdocs' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Amdocs (FRA:AOS), the current YoY EBITDA Growth is -34.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amdocs (FRA:AOS) Overvalued in 2026?

Based on GuruFocus' analysis, Amdocs stock appears to be undervalued. The current stock price of €52.92 is trading 29.6% below its estimated GF Value™ of €75.21. GuruFocus considers Amdocs to be Significantly Undervalued.

Key valuation signals for FRA:AOS:

  • YoY EBITDA Growth: -34.00%
  • GF Value™: €75.21 vs. price of €52.92 (29.6% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the FRA:AOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amdocs Business Description

Address 625 Maryville Centre Drive, Suite 200, Saint Louis, MO, USA, 63141
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
72GF Score

Get the complete analysis for FRA:AOS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.92
Price
€75.21
GF Value